Publicaciones (414) Publicaciones de JOSÉ LUIS MARCO CONTELLES

2024

  1. Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases

    Biomolecules, Vol. 14, Núm. 5

  2. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555

  3. Discovery of New Highly Potent Histamine H3 Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors

    ACS Chemical Neuroscience, Vol. 15, Núm. 18, pp. 3363-3383

  4. Efficient Two-Step Synthesis of Novel Pyrimido[4,5-d] Pyrimidines with Potent Neuroprotective, Antioxidant, and Aβ Anti-Aggregation Properties

    Chemistry (Switzerland), Vol. 6, Núm. 4, pp. 695-705

  5. Hydrazides as Inhibitors of Histone Deacetylases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 16, pp. 13512-13533

  6. In Vitro Modulation of Autophagy by New Antioxidant Nitrones as a Potential Therapeutic Approach for the Treatment of Ischemic Stroke

    Antioxidants, Vol. 13, Núm. 8

  7. Permselectivity of Silk Fibroin Hydrogels for Advanced Drug Delivery Neurotherapies

    Biomacromolecules, Vol. 25, Núm. 8, pp. 5233-5250

  8. Synthesis and Antioxidant Activity of N-Benzyl-2-[4-(aryl)-1H-1,2,3-triazol-1-yl]ethan-1-imine Oxides

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  9. Synthesis and Biological Evaluation of New Benzochromenopyrimidines for the Therapy of Colon and Lung Cancer

    ChemistrySelect, Vol. 9, Núm. 2

  10. Synthesis, antioxidant and neuroprotective analysis of diversely functionalized α-aryl-N-alkyl nitrones as potential agents for ischemic stroke therapy

    European Journal of Medicinal Chemistry, Vol. 266

  11. The proof of concept of 2-{3-[N-(1-benzylpiperidin-4-yl)propyl]amino}-6-[N-methyl-N-(prop-2-yn-1-yl)amino]-4-phenylpyridine-3,5-dicarbonitrile for the therapy of neuropathic pain

    Bioorganic Chemistry, Vol. 150

  12. α-Phenyl-N-tert-Butylnitrone and Analogous α-Aryl-N-alkylnitrones as Neuroprotective Antioxidant Agents for Stroke

    Antioxidants, Vol. 13, Núm. 4

2023

  1. 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases

    Acta Pharmaceutica Sinica B, Vol. 13, Núm. 5, pp. 2152-2175

  2. Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation

    Molecules, Vol. 28, Núm. 1

  3. Design, Synthesis, in Silico and Biological Evaluation of Novel 4-Aminopyrimidine-5-carbonitriles

    ChemistrySelect, Vol. 8, Núm. 31

  4. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment

    International Journal of Molecular Sciences, Vol. 24, Núm. 11

  5. Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death

    Antioxidants, Vol. 12, Núm. 7

  6. Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models

    Scientific Reports, Vol. 13, Núm. 1

  7. Synthesis and Antioxidant Properties of Novel 1,2,3-Triazole-Containing Nitrones

    Antioxidants, Vol. 12, Núm. 1

  8. The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy

    International Journal of Molecular Sciences, Vol. 24, Núm. 15